This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Anatabloc® was chosen to receive the award based on several criteria, including: success in bringing a product into a mature, competitive category; success in establishing the product with effective marketing, sampling, and trial drivers; and success in becoming a best-selling new product.
"We could not ask for a better partner than GNC," stated
David Dean, Vice President of Sales and Marketing for Star Scientific, Inc. "The growth of Anatabloc® and increase in awareness of the product over the past year could not have happened without the support of GNC. We are honored to have been chosen for this award."
Tom Dowd, Executive Vice President, Chief Merchandising Officer & General Manager of GNC, stated, "Sales of Anatabloc® continue to surpass our expectations. We are proud to recognize Star Scientific and Anatabloc® with the 2012 GNC Top Vendor Award for Best Product Innovation in the Wellness category."
Recently, the Company increased the number of lozenges/tablets in both Anatabloc® and Anatabloc® Unflavored from 200 to 300, an increase of 50% over the former quantity. This change was made after researchers for the Company developed a new recommended usage of the products based on body weight. The weight classification and usage recommendation chart is now displayed on Anatabloc® packaging and on the Anatabloc® website (
www.anatabloc.com). The transition from the 200-count to the 300-count bottle will be complete in all GNC stores during the month of April.
Also, the Company is pleased to announce that the Anatabloc® Rare Cellular Facial Creme is now available for sale on GNC's website (
www.GNC.com) and on the Anatabloc® website (
www.anatabloc.com). A related Anatabloc® facial cleanser and serum are in development.
Certain statements contained in this release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to statements identified by words such as "believes," "expects," "anticipates," "estimates," "intends," "plans," "targets," "projects" and similar expressions. The statements in this release are based upon the current beliefs and expectations of our company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. Numerous factors could cause or contribute to such differences, including, but not limited to, results of clinical trials and/or other studies, the challenges inherent in new product development initiatives, including the continued development and market acceptance of our nutraceutical dietary supplements products, the effect of any competitive products, our ability to license and protect our intellectual property, our ability to raise additional capital in the future that is necessary to maintain our business, changes in government policy and/or regulation, potential litigation by or against us and any governmental review of our products or practices, as well as other risks discussed from time to time in our filings with the Securities and Exchange Commission, including, without limitation, our annual report on Form 10-K for the fiscal year ended
December 31, 2012. We undertake no duty to update any forward-looking statement or any information contained in this press release or in other public disclosures at any time.
About Star Scientific Star Scientific, Inc. is a technology-oriented company with a mission to promote maintenance of a healthy metabolism and lifestyle. Through its wholly owned subsidiary, Rock Creek Pharmaceuticals, Star Scientific has been engaged in the manufacturing, sale, and marketing of two nutraceutical dietary supplements, a cosmetic facial cream, and the development of other nutraceuticals and pharmaceuticals. The company also continues to pursue the licensing of the technology behind its proprietary StarCured® curing process and its related products. Rock Creek Pharmaceuticals has scientific and research offices in
Gloucester, MA, and a regulatory office in
Washington, DC. Star Scientific has a Corporate and Sales Office in
Glen Allen, VA, and an Executive, Scientific & Regulatory Affairs office in
Talhia T. Tuck Vice President, Communications and Investor Relations Star Scientific, Inc. (202)887-5100
SOURCE Star Scientific, Inc.